Company Filing History:
Years Active: 2005-2012
Title: Innovations by Inventor Xiaoli Chen
Introduction
Xiaoli Chen is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and related conditions. With a total of 4 patents to his name, his work has had a considerable impact on medical therapies.
Latest Patents
Xiaoli Chen's latest patents include innovative combination therapies. One patent focuses on a combination therapy comprising glucose reabsorption inhibitors and PPAR modulators. This therapy is useful for the treatment of diabetes and Syndrome X. Another patent involves a combination therapy that includes glucose reabsorption inhibitors and retinoid-X receptor modulators, also aimed at treating diabetes and Syndrome X.
Career Highlights
Throughout his career, Xiaoli Chen has worked with prominent companies in the pharmaceutical industry. He has been associated with Ortho-McNeil Pharmaceutical Corporation and Janssen Pharmaceutica NV. His experience in these organizations has allowed him to develop and refine his innovative ideas.
Collaborations
Xiaoli Chen has collaborated with several professionals in his field. Notable coworkers include Keith T. Demarest and Jacqueline C. Bussolari, who have contributed to his research and development efforts.
Conclusion
Xiaoli Chen's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in diabetes treatment and related therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.